Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Ivermectin  COVID-19 treatment studies for Ivermectin  C19 studies: Ivermectin  Ivermectin   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta
Other Treatments Global Adoption
▶
▶
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Mortality 27% no CI Improvement Relative Risk Death/ICU 38% no CI Mortality (b) 33% no CI Mortality (c) 44% no CI c19ivm.org La Pampa et al. Ivermectin for COVID-19 EARLY Is early treatment with ivermectin beneficial for COVID-19? Retrospective 21,418 patients in Argentina Lower mortality with ivermectin La Pampa, Argentina Favors ivermectin Favors control
La Pampa expondrá a la comunidad científica los resultados del Programa de Intervención Monitoreado de Ivermectina
La Pampa, Argentina (News)
La Pampa, La Pampa expondrá a la comunidad científica los resultados del Programa de Intervención Monitoreado de.., , Argentina (News)
Aug 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
News report on the use of ivermectin in La Pampa, Argentina, showing lower mortality with treatment. This study is excluded in the after exclusion results of meta analysis: minimal details provided.
Important missing comments or errors? Let us know.
risk of death, 27.4% lower, RR 0.73, treatment 3,269, control 18,149.
risk of death/ICU, 38.0% lower, RR 0.62, treatment 3,269, control 18,149.
risk of death, 33.4% lower, RR 0.67, treatment 3,269, control 18,149, >40yo.
risk of death, 44.0% lower, RR 0.56, treatment 3,269, control 18,149, >40yo including comorbidities.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
La Pampa et al., 10 Aug 2021, retrospective, Argentina, preprint, 1 author, dosage 600μg/kg days 1-5.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperIvermectinAll
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit    
Share
Tweet
@CovidAnalysis
FAQ
Public domain CC0 1.0